Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hammerson lifts profit guidance, takes full control of Bullring-Grand Central

(Sharecast News) - Retail and leisure-focused real estate group Hammerson has raised its earnings outlook as it unveiled the acquisition of the remaining 50% stake in the Bullring and Grand Central shopping centres in Birmingham for £319m. The deal for Bullring and Grand Central gives the company full control of a "super prime destination", which has delivered "standout operational and financial performance in recent years", with footfall up 3% at 33m visitors in 2024 and up a further 5% in the first half of 2025.

The company said it was suspending its share buyback as it intends to raise up to 10% of its existing issued share capital through an institutional placing to fund the acquisition, with the financed from existing cash resources.

"This is an exciting milestone for Hammerson. Our investment alongside key trusted brand partners has seen Bullring deliver a standout operational performance in recent years, cementing its reputation as a top five UK destination," said chief executive Rita-Rose Gagné.

The news came as Hammerson delivered its first-half results, in which like-for-like gross rental income rose 5% to £105m, or 11% including the impact of acquisitions.

The company, who saw an 11% uplift in the value of its portfolio to £2.96bn over the six months to 30 June, recorded a net profit of £79m compared with a loss of £517m the year before.

Underlying earnings were down 3% at £48m due to disposals and the phasing of redeployment, but still ahead of expectations, leading to a 5% increase in the interim dividend to 7.94p per share.

As a result of the strong first half, Hammerson lifted its guidance for GRI growth to 17% and for underlying earnings to £102m, up from earlier forecasts of 10% and £95m, respectively.

Shares were up 1.8% at 299.6p by 0859 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.